J P. Sedelaar-Michiel
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Lutetium-177-PSMA-617 in Oligo-metastatic Hormone-sensitive Prostate Cancer (BULLSEYE): A Trial Update.
Journal: European urology focus
Published: April 14, 2026
Efficacy of Treatments for T3bN0M0 Prostate Cancer Patients: A Systematic Review and Meta-Analysis.
Journal: The Prostate
Published: March 31, 2025
Evaluation of complications and biochemical recurrence rates after (super) extended lymph node dissection during radical prostatectomy.
Journal: World journal of urology
Published: May 07, 2024
The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association-defined Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b Study.
Journal: European urology open science
Published: January 24, 2024
How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come.
Journal: European urology
Published: June 07, 2022
A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging-directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naïve Men.
Journal: European urology
Published: November 03, 2021
Yield of Repeat Targeted Direct in-Bore Magnetic Resonance-Guided Prostate Biopsy (MRGB) of the Same Lesions in Men Having a Prior Negative Targeted MRGB.
Journal: Korean journal of radiology
Published: October 10, 2017
Of mice and men--warning: intact versus castrated adult male mice as xenograft hosts are equivalent to hypogonadal versus abiraterone treated aging human males, respectively.
Journal: The Prostate
Published: March 11, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026